Compliance Insight was recently named a Top 10 Quality Assurance Service Company – 2021 by Pharma Tech Outlook.
This annual award recognizes 10 companies that are at the forefront of providing Quality
Assurance consulting/services and transforming business. According to Troy Fugate, Vice President,
Compliance Insight, “This award is a reflection of the hard work, dedication, and tireless energy of all
our colleagues at Compliance Insight. Receiving this award validates that going beyond the hard work, to
compliance that makes sense, is how extraordinary quality is delivered.”
Fugate explained how Compliance Insight’s growth and success have mirrored its clients’, “If our goal
as a company is to make a difference in the world, we are well on our way to achieving success‒and
we are not finished yet. With new concepts of coaching and mentoring being implemented through our
MRE program and PEPPER concept, we are paving new roads for educating our partners and, ultimately,
ensuring their success.”
Fugate feels the award reflects and validates the thorough and thoughtful work he and his Compliance
Insight colleagues have put into building a company culture that is unique in Quality Compliance:
a culture that includes compliance with regulations and to commitment, conduct, and ethics.
Pharma Tech Outlook, the monthly publication that recognized Compliance Insight’s efforts, “brings
a clear insight into design, development, manufacture, evaluation, and dosage of drug delivery
systems including breakthroughs in pharmaceutical infrastructure, tools, and equipments.” They “aim
at contributing to the transformation of innovations into services as well as creating a healthy and
productive ecosystem.”
Learn more about the end-to-end compliance and process development consulting services Compliance
Insight has been offering for over 20 years, including helping companies in the pharmaceutical, biologic,
medical device, and gene and cell therapy sectors navigate regulatory submissions and obtain FDA approval.
Click here to read the article on Pharma Tech Outlook!